tci Medicare Compliance & Reimbursement - 2005 Issue 27
PHARMACEUTICALS: Dramatic Payment Drops Set For Common Drugs
New rates could hit hardest in smaller offices.Even though the Centers for Medicare and Medicaid Services has been collecting information from physicians who say they can't obtain drugs at the rock-bottom prices Medicare has been paying, the newest numbers don't show much improvement for payments. CMS released the latest drug rates, based on 106 percent of Average Sales Price data, and many chemotherapy drugs were treated to sharp decreases.The hardest hit include Cytarabine, which dropped around 38 percent; Etoposide, which dropped around 33 percent; and Carboplatin injection, which fell to around 31 percent. CMS insisted that...
To read the full article, sign in and subscribe to tci Medicare Compliance & Reimbursement.
Thank you for choosing Find-A-Code, please Sign In to remove ads.